Lastest Insider Transactions Of NovoCure Ltd ( NVCR )
SymbolCompany NameInsider NameTitleDateTransationSharePriceAmountFile Date
NVCRNovoCure LtdLeonard Frank XEVP, Pres., Novocure Oncology2024-03-01Sell2,51916.0240,3582024-03-05 16:08:02
NVCRNovoCure LtdLeonard Frank XEVP, Pres., Novocure Oncology2024-02-27Sell2,07816.1433,5452024-02-29 16:38:56
NVCRNovoCure LtdGROENHUYSEN WILHELMUS CMChief Operating Officer2024-02-27Sell2,30316.1437,1772024-02-29 16:28:11
NVCRNovoCure LtdShah PriteshChief Growth Officer2023-11-07Sell38212.654,8322023-11-08 16:22:37
NVCRNovoCure LtdCordova AshleyChief Financial Officer2023-10-31Option Exercise17,9689.60172,4532023-11-02 16:20:51
NVCRNovoCure LtdCordova AshleyChief Financial Officer2023-09-01Sell88321.8219,2652023-09-05 16:24:39
NVCRNovoCure LtdGROENHUYSEN WILHELMUS CMChief Operating Officer2023-09-01Sell29421.826,4142023-09-05 16:24:18
NVCRNovoCure LtdShah PriteshChief Growth Officer2023-09-01Sell27321.825,9562023-09-05 16:23:32
NVCRNovoCure LtdCordova AshleyChief Financial Officer2023-08-02Sell1,14430.2534,6072023-08-04 16:02:21
NVCRNovoCure LtdLeonard Frank XPresident, CNS Cancers US2023-03-03Sell13,60975.551,028,1652023-03-07 16:52:16
NVCRNovoCure LtdShah PriteshChief Growth Officer2023-03-03Sell21,42176.161,631,4112023-03-07 16:52:00
NVCRNovoCure LtdGROENHUYSEN WILHELMUS CMChief Operating Officer2023-03-03Sell25,63576.161,952,3462023-03-07 16:51:48
NVCRNovoCure LtdCordova AshleyChief Financial Officer2023-03-03Sell5,50576.16419,2582023-03-07 16:51:15
NVCRNovoCure LtdBurke William PatrickChief Human Resources Officer2023-03-03Sell59376.1645,1632023-03-07 16:50:35
NVCRNovoCure LtdBurke William PatrickChief Human Resources Officer2023-03-02Sell28175.2821,1532023-03-06 16:42:42
NVCRNovoCure LtdShah PriteshChief Growth Officer2023-03-02Sell93775.2870,5352023-03-06 16:41:07
NVCRNovoCure LtdGROENHUYSEN WILHELMUS CMChief Operating Officer2023-03-02Sell1,21375.2891,3122023-03-06 16:40:52
NVCRNovoCure LtdCordova AshleyChief Financial Officer2023-03-02Sell1,05575.2879,4182023-03-06 16:40:12
NVCRNovoCure LtdLeonard Frank XPresident, CNS Cancers US2023-03-02Sell2,90376.95223,3932023-03-06 16:37:48
NVCRNovoCure LtdLeonard Frank XPresident, CNS Cancers US2023-03-02Sell4,10775.38309,5782023-03-03 16:13:03
NVCRNovoCure LtdLeonard Frank XPresident, CNS Cancers US2023-02-28Sell1,68476.36128,5942023-03-02 17:01:17
NVCRNovoCure LtdShah PriteshChief Growth Officer2023-02-28Sell1,92376.36146,8452023-03-02 17:00:09
NVCRNovoCure LtdCordova AshleyChief Financial Officer2023-02-28Sell2,19876.36167,8452023-03-02 16:55:26
NVCRNovoCure LtdBurke William PatrickChief Human Resources Officer2023-02-28Sell75576.3657,6542023-03-02 16:51:19
NVCRNovoCure LtdGROENHUYSEN WILHELMUS CMChief Operating Officer2023-02-28Sell2,16476.36165,2482023-03-02 16:49:32
NVCRNovoCure LtdWeinberg UriChief Science Officer2023-01-05Sell8,143116.14945,7562023-01-09 18:24:06
NVCRNovoCure LtdWeinberg UriChief Science Officer2023-01-05Option Exercise1,94647.0491,5402023-01-09 18:24:06
NVCRNovoCure LtdLeonard Frank XPresident, CNS Cancers US2023-01-05Sell39,507112.254,434,6542023-01-09 18:21:59
NVCRNovoCure LtdLeonard Frank XPresident, CNS Cancers US2023-01-05Option Exercise35,20915.39541,6972023-01-09 18:21:59
NVCRNovoCure LtdShah PriteshChief Commercial Officer2023-01-05Sell387108.0041,7962023-01-09 18:20:06
NVCRNovoCure LtdDanziger AsafChief Executive Officer2023-01-05Sell212,500108.7423,106,2302023-01-09 18:18:44
NVCRNovoCure LtdDanziger AsafChief Executive Officer2023-01-05Option Exercise212,5007.661,627,1252023-01-09 18:18:44